GlassScriptPhysician profile
Muhammad Fuad Jan
NPI 1912956178
$10,960.81
in general payments reported to CMS, 2019-2025
15 companies · $5,143 in 2025
The $5,143 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2021: $266 · 2022: $1,288 · 2023: $3,080 · 2024: $1,025 · 2025: $5,143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,216 · Consulting Fee: $2,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Food and Beverage: $999 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,216.47 |
| Consulting Fee | $2,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Food and Beverage | $999.19 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Circulation INC | $7,342.26 | 2023-2025 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Abbott Laboratories | $1,213.95 | 2024-2025 | Dragonfly Opstar, Mitraclip, Amplatzer Amulet |
| Boston Scientific Corporation | $1,040.78 | 2022 | |
| Medtronic, INC. | $420.49 | 2021-2025 | Onyx Frontier, Corevalve Evolut R, Pipeline |
| Edwards Lifesciences Corporation | $268.70 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $198.00 | 2019-2022 | |
| Cvrx, INC. | $147.66 | 2025 | Barostim Neo System |
| Terumo Medical Corporation | $117.29 | 2025 | R2p Misago |
| Shockwave Medical, INC | $111.29 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Akcea Therapeutics, INC. | $59.45 | 2019 | |
| Novo Nordisk INC | $32.27 | 2023 | Ozempic |
| Cardiovascular Systems INC. | $8.67 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Jan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.